BIONTECH SE - AMERICAN
111.00
08-November-24 15:36:14
15 minutes delayed
Stocks
+3.12
+2.89%
Today's range
110.01 - 115.32
ISIN
N/A
Source
NASDAQ
-
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
23 Dec 2022 03:00:00 By Nasdaq GlobeNewswire
-
22 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
Update on First BioNTainer for African-based mRNA Manufacturing Facility
21 Dec 2022 08:45:00 By Nasdaq GlobeNewswire
-
21 Dec 2022 06:45:00 By Nasdaq GlobeNewswire
-
09 Dec 2022 06:45:00 By Nasdaq GlobeNewswire
-
08 Dec 2022 10:39:34 By Nasdaq GlobeNewswire
-
30 Nov 2022 01:02:35 By Nasdaq GlobeNewswire
-
18 Nov 2022 06:45:00 By Nasdaq GlobeNewswire
-
16 Nov 2022 18:30:00 By Nasdaq GlobeNewswire
-
13 Nov 2022 20:30:00 By Nasdaq GlobeNewswire
-
10 Nov 2022 09:45:00 By Nasdaq GlobeNewswire
-
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
07 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
12 Oct 2022 10:30:00 By Nasdaq GlobeNewswire
-
25 Jun 2022 10:02:16 By Nasdaq GlobeNewswire
-
15 Mar 2022 18:00:00 By Nasdaq GlobeNewswire
-
08 Mar 2022 08:27:07 By Nasdaq GlobeNewswire
-
21 Feb 2022 13:25:00 By Nasdaq GlobeNewswire
-
16 Feb 2022 05:30:00 By Nasdaq GlobeNewswire
-
15 Feb 2022 09:40:00 By Nasdaq GlobeNewswire